Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
UroGen Pharma Ltd. (URGN)
USD40.12
+0.61 (+1.54%)
US NASDAQ Healthcare Biotechnology
Address
400 Alexander Park Drive 8540
Princeton, NJ, US
Princeton, NJ, US
CEO
Elizabeth Barrett
Website
urogen.com
IPO
2017-05-04
CIK 1668243 ISIN IL0011407140
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a sustained-release formulation of mitomycin for the treatment of non-muscle invasive bladder cancer (NMIBC); and Jelmyto for pyelocalyceal solutions. The company’s lead product candidates are UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that is in phase 3 of clinical trial for pyelocalyceal solution designed for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk NMIBC. It is also developing UGN-301, UGN-301+UGN 201, and UGN-301+gemcitabine that are in phase 1 of clinical trial for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 and UGN-104. UroGen Pharma Ltd. was incorporated in 2004 and is headquartered in Princeton, New Jersey.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD40.12
+0.61 (+1.54%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
793.6K
Beta
1.62
Float Shares
38.66M
Free Float %
79.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.88% | +12.84% | +38.15% | +47.45% | +18.54% | +27.24% | +167.50% | +147.30% | +64.10% | +113.16% | +113.16% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
40.12
Low
40.00
-0.3%
Consensus
42.50
+5.9%
Median
42.50
+5.9%
High
45.00
+12.2%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
40.00
-0.3%
|
| Last Quarter | 1 |
40.00
-0.3%
|
| Last Year | 3 |
29.00
-27.7%
|
| All Time | 11 |
33.55
-16.4%
|
Quality scores
Altman Z-Score
-3.26
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+21.5% ★ Q1'26: +151.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-7.8% Q1'26: +48.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-180.2% Q1'26: -89.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-125.8% Q1'26: -39.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +98.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+12.2% Q1'26: +5.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.95× Q1'26: -2.51× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 6 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.16M
est: 7.85M (+3.9%)
|
1.13M
est: 1.13M (-0.6%)
|
18.0K
est: 18.0K (+0.0%)
|
11.80M
est: 11.51M (+2.5%)
|
48.04M
est: 48.11M (-0.1%)
|
64.36M
est: 64.78M (-0.7%)
|
82.71M
est: 85.01M (-2.7%)
|
90.40M
est: 91.00M (-0.7%)
|
109.79M
est: 111.88M (-1.9%)
|
262.36M
240.29M – 302.48M
+134.5% YoY
|
435.53M
384.99M – 488.34M
+66.0% YoY
|
560.15M
560.15M – 560.15M
+28.6% YoY
|
797.38M
704.08M – 953.63M
+42.4% YoY
|
1.00B
887.16M – 1.20B
+26.0% YoY
|
| EBITDA |
-19.74M
est: -7.43M (-165.7%)
|
-77.18M
est: -58.84M (-31.2%)
|
-108.15M
est: -17.0K (-635,128.5%)
|
-122.71M
est: -10.89M (-1,026.7%)
|
-91.46M
est: -45.50M (-101.0%)
|
-76.21M
est: -61.28M (-24.4%)
|
-60.35M
est: -80.41M (+24.9%)
|
-95.35M
est: -86.08M (-10.8%)
|
-135.66M
est: -105.83M (-28.2%)
|
-248.17M
-286.13M – -227.30M
-134.5% YoY
|
-411.98M
-461.93M – -364.18M
-66.0% YoY
|
-529.86M
-529.86M – -529.86M
-28.6% YoY
|
-754.27M
-902.07M – -666.01M
-42.4% YoY
|
-950.39M
-1.14B – -839.19M
-26.0% YoY
|
| EBIT |
-19.95M
est: -7.46M (-167.4%)
|
-77.18M
est: -60.09M (-28.4%)
|
-109.48M
est: -17.1K (-640,122.2%)
|
-124.75M
est: -10.94M (-1,040.5%)
|
-92.29M
est: -45.70M (-101.9%)
|
-78.03M
est: -61.55M (-26.8%)
|
-62.06M
est: -80.77M (+23.2%)
|
-95.68M
est: -86.45M (-10.7%)
|
-138.07M
est: -106.29M (-29.9%)
|
-249.25M
-287.37M – -228.29M
-134.5% YoY
|
-413.77M
-463.95M – -365.76M
-66.0% YoY
|
-532.17M
-532.17M – -532.17M
-28.6% YoY
|
-757.55M
-906.00M – -668.92M
-42.4% YoY
|
-954.54M
-1.14B – -842.85M
-26.0% YoY
|
| Net Income |
-20.00M
est: -85.83M (+76.7%)
|
-75.66M
est: -58.92M (-28.4%)
|
-105.15M
est: -212.29M (+50.5%)
|
-128.48M
est: -253.88M (+49.4%)
|
-110.82M
est: -206.74M (+46.4%)
|
-109.78M
est: -209.72M (+47.7%)
|
-102.24M
est: -165.57M (+38.2%)
|
-126.87M
est: -149.51M (+15.1%)
|
-153.49M
est: -152.87M (-0.4%)
|
-39.62M
-80.39M – -10.50M
+74.1% YoY
|
94.65M
23.13M – 143.41M
+338.9% YoY
|
210.78M
124.60M – 258.41M
+122.7% YoY
|
281.29M
238.50M – 352.94M
+33.4% YoY
|
368.76M
312.67M – 462.70M
+31.1% YoY
|
| SGA |
8.81M
est: 15.80M (-44.2%)
|
39.57M
est: 2.28M (+1,633.6%)
|
60.20M
est: 36.2K (+166,103.8%)
|
90.22M
est: 23.17M (+289.4%)
|
—
est: 96.80M (-100.0%)
|
82.84M
est: 130.36M (-36.5%)
|
93.27M
est: 65.08M (+43.3%)
|
—
est: 69.66M (-100.0%)
|
155.10M
est: 85.64M (+81.1%)
|
200.84M
183.94M – 231.55M
+134.5% YoY
|
333.40M
294.72M – 373.82M
+66.0% YoY
|
428.80M
428.80M – 428.80M
+28.6% YoY
|
610.40M
538.98M – 730.01M
+42.4% YoY
|
769.12M
679.13M – 919.83M
+26.0% YoY
|
| EPS |
-2.06
est: -2.00 (-2.9%)
|
-4.80
est: -4.47 (-7.3%)
|
-4.90
est: -4.95 (+1.0%)
|
-5.90
est: -5.92 (+0.4%)
|
-4.96
est: -4.82 (-2.9%)
|
-4.79
est: -4.52 (-6.0%)
|
-3.55
est: -3.27 (-8.5%)
|
-2.96
est: -3.13 (+5.4%)
|
-3.19
est: -3.20 (+0.2%)
|
-0.95
-1.67 – -0.22
+70.3% YoY
|
1.39
0.48 – 2.98
+246.4% YoY
|
3.24
2.59 – 5.37
+133.3% YoY
|
5.85
4.96 – 7.34
+80.4% YoY
|
7.66
6.50 – 9.62
+31.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-162.33M
OE per share TTM
-3.33
Owner's Yield
-12.32%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
7.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
34
Total invested
47.87M
Insider transactions (90d)
0
Beneficial owners (>5%)
44
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Management, L.P. | 3.74M | 8.87% | — | 3.74M | — | — | IA, PN | Delaware | 2024-11-12 | ↗ |
| 2 | Phillip Gross | 3.74M | 8.87% | — | 3.74M | — | — | HC, IN | Delaware | 2024-11-12 | ↗ |
| 3 | Robert Atchinson | 3.74M | 8.87% | — | 3.74M | — | — | HC, IN | Delaware | 2024-11-12 | ↗ |
| 4 | Peter Kolchinsky | 3.08M | 9.99% | — | 3.08M | — | 3.08M | HC, IN | Delaware | 2023-12-29 | ↗ |
| 5 | RA Capital Healthcare Fund, L.P. | 3.08M | 9.99% | — | 3.08M | — | 3.08M | PN | Delaware | 2023-12-29 | ↗ |
| 6 | RA Capital Management, L.P. | 3.08M | 9.99% | — | 3.08M | — | 3.08M | IA, PN | Delaware | 2023-12-29 | ↗ |
| 7 | Rajeev Shah | 3.08M | 9.99% | — | 3.08M | — | 3.08M | HC, IN | Delaware | 2023-12-29 | ↗ |
| 8 | Menora Mivtachim Holdings Ltd. | 2.95M | 13.37% | — | 2.95M | — | — | CO | Israel | 2021-02-11 | ↗ |
| 9 | Dr. Jeffrey R. Jay, M.D. | 2.62M | 8.51% | — | 2.62M | — | — | HC, IN | USA | 2023-09-15 | ↗ |
| 10 | Great Point Partners, LLC | 2.62M | 8.51% | — | 2.62M | — | — | IA, OO | Delaware | 2023-09-15 | ↗ |
| 11 | Mr. Ortav Yehudai | 2.62M | 8.51% | — | 2.62M | — | — | HC, IN | USA | 2023-09-15 | ↗ |
| 12 | Point72 Asset Management, L.P. | 2.57M | 6.20% | — | 2.57M | — | — | PN | Delaware | 2024-06-24 | ↗ |
| 13 | Point72 Capital Advisors, Inc. | 2.57M | 6.20% | — | 2.57M | — | — | CO | Delaware | 2024-06-24 | ↗ |
| 14 | Steven A. Cohen | 2.57M | 6.20% | — | 2.57M | — | — | IN | Delaware | 2024-06-24 | ↗ |
| 15 | Menora Mivtachim Pensions and Gemel Ltd. | 2.50M | 11.33% | — | 2.50M | — | — | CO | Israel | 2021-02-11 | ↗ |
| 16 | (1)Names of reporting persons. BlackRock, Inc. | 2.50M | 5.90% | — | — | 2.50M | — | HC | Delaware | 2024-10-24 | ↗ |
| 17 | BlackRock, Inc. | 2.50M | 5.90% | 2.45M | — | 2.50M | — | HC | Delaware | 2024-11-08 | ↗ |
| 18 | Morgan Stanley | 2.17M | 5.20% | — | 2.15M | — | 2.17M | HC, CO | Delaware. | 2024-11-06 | ↗ |
| 19 | RTW Investments, LP | 1.73M | 5.60% | — | 1.73M | — | — | IA, PN | Delaware | 2024-02-14 | ↗ |
| 20 | Roderick Wong, M.D. | 1.73M | 5.60% | — | 1.73M | — | — | HC, IN | United States | 2024-02-14 | ↗ |
| 21 | Fred Cohen | 1.66M | 5.40% | 90.0K | 1.57M | 90.0K | 1.57M | IN | — | 2023-08-04 | ↗ |
| 22 | Charles Conn | 1.57M | 5.10% | — | 1.57M | — | 1.57M | IN | — | 2023-08-04 | ↗ |
| 23 | Monograph Capital Holdings Advisors, LLC | 1.57M | 5.10% | — | 1.57M | — | 1.57M | OO | — | 2023-08-04 | ↗ |
| 24 | Monograph Capital Partners I GenPar, LP | 1.57M | 5.10% | — | 1.57M | — | 1.57M | PN | — | 2023-08-04 | ↗ |
| 25 | Monograph Capital Partners I, L.P. | 1.57M | 5.10% | — | 1.57M | — | 1.57M | PN | — | 2023-08-04 | ↗ |
| 26 | A. Potter | 1.16M | 5.51% | — | 1.16M | — | — | IN | United States | 2020-02-14 | ↗ |
| 27 | CREDIT SUISSE AG/000000000 | 1.09M | 4.84% | — | 1.09M | — | 1.09M | BK, HC | — | 2022-02-14 | ↗ |
| 28 | Infinity Q Capital Management, LLC | 719.1K | 3.26% | — | 719.1K | — | — | IA | Delaware | 2021-02-12 | ↗ |
| 29 | Infinity Q Diversified Alpha Fund | 719.1K | 3.26% | — | 719.1K | — | — | IV | Delaware | 2021-02-12 | ↗ |
| 30 | Infinity Q Management Equity, LLC | 719.1K | 3.26% | — | 719.1K | — | — | OO | Delaware | 2021-02-12 | ↗ |
| 31 | James Velissaris | 719.1K | 3.26% | — | 719.1K | — | — | IN | United States | 2021-02-12 | ↗ |
| 32 | Scott H. Lindell | 719.1K | 3.26% | — | 719.1K | — | — | IN | United States | 2021-02-12 | ↗ |
| 33 | Q Capital Management, LLC | 622.7K | 2.97% | — | 622.7K | — | — | IA | Delaware | 2020-02-14 | ↗ |
| 34 | Q Diversified Alpha Fund | 622.7K | 2.97% | — | 622.7K | — | — | IV | Delaware | 2020-02-14 | ↗ |
| 35 | Q Management Equity, LLC | 622.7K | 2.97% | — | 622.7K | — | — | OO | Delaware | 2020-02-14 | ↗ |
| 36 | Velissaris | 622.7K | 2.97% | — | 622.7K | — | — | IN | United States | 2020-02-14 | ↗ |
| 37 | Family Limited Partnership | 533.1K | 2.54% | — | 533.1K | — | — | PN | Texas | 2020-02-14 | ↗ |
| 38 | Bonderman Family Limited Partnership | 533.1K | 2.40% | — | 533.1K | — | — | PN | Texas | 2022-02-14 | ↗ |
| 39 | Leonard A. Potter | 533.1K | 2.40% | — | 533.1K | — | — | IN | United States | 2022-02-14 | ↗ |
| 40 | Wildcat Capital Management, LLC | 533.1K | 2.40% | — | 533.1K | — | — | IA | Delaware | 2022-02-14 | ↗ |
| 41 | 38-3698933 | 500.0K | 1.21% | 500.0K | — | 500.0K | — | — | Delaware | 2024-06-24 | ↗ |
| 42 | Wildcat – Liquid Alpha, LLC | 148.3K | 0.70% | — | 148.3K | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 43 | Stonepine Capital Management, LLC | 9.00 | 5.20% | — | 1.20M | — | 1.20M | IA, OO | California | 2022-12-01 | ↗ |
| 44 | Mitchell Blutt | — | 0.00% | — | — | — | — | HC, IN | USA | 2020-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
34
-141 vs prev Q
New positions
7
Closed positions
141
Increased
16
Reduced
7
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 100.0K +100.0K (+100.0%) | 2.34B +2.3B (+100.0%) | 0.21% +0.208 pp | 0.69% +0.691 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 2 | RTW INVESTMENTS, LP | 4.54M +— (+0.0%) | 106.42M +15.8M (+17.4%) | 9.46% -0.063 pp | 1.07% -0.051 pp | USD14.81 +58.1% | 18 qtrs — |
| 3 | PARADIGM BIOCAPITAL ADVISORS LP | 4.47M +257.6K (+6.1%) | 104.77M +20.7M (+24.6%) | 9.31% +0.478 pp | 2.67% +0.282 pp | USD20.15 +16.2% | 2 qtrs — |
| 4 | BLACKROCK, INC. | 2.60M +19.7K (+0.8%) | 60.92M +9.4M (+18.3%) | 5.41% +0.005 pp | 0.00% +0.000 pp | USD13.27 +76.5% | 6 qtrs — |
| 5 | MORGAN STANLEY | 2.56M +34.5K (+1.4%) | 60.02M +9.6M (+19.0%) | 5.33% +0.037 pp | 0.00% +0.001 pp | USD14.39 +62.8% | 34 qtrs — |
| 6 | JEFFERIES FINANCIAL GROUP INC. | 2.20M +— (+0.0%) | 51.52M +7.6M (+17.4%) | 4.58% -0.030 pp | 0.26% +0.056 pp | USD13.99 +67.4% | 8 qtrs — |
| 7 | SILVERARC CAPITAL MANAGEMENT, LLC | 1.74M +161.5K (+10.2%) | 40.72M +9.3M (+29.4%) | 3.62% +0.314 pp | 5.66% +1.413 pp | USD14.66 +59.8% | 10 qtrs — |
| 8 | ACORN CAPITAL ADVISORS, LLC | 1.45M +188.7K (+15.0%) | 33.92M +8.8M (+35.0%) | 3.01% +0.375 pp | 11.49% -1.264 pp | USD12.31 +90.3% | 5 qtrs — |
| 9 | SG AMERICAS SECURITIES, LLC | 1.38M +220.3K (+19.0%) | 32.26M +9.2M (+39.7%) | 2.87% +0.442 pp | 0.04% -0.037 pp | USD15.00 +56.1% | 6 qtrs — |
| 10 | AMERICAN CENTURY COMPANIES INC | 1.36M +1.4M (+100.0%) | 31.82M +31.8M (+100.0%) | 2.83% +2.828 pp | 0.02% +0.016 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 11 | MENORA MIVTACHIM HOLDINGS LTD. | 1.15M +— (+0.0%) | 26.99M +4.0M (+17.4%) | 2.40% -0.016 pp | 0.13% +0.010 pp | USD39.66 -40.9% | 35 qtrs — |
| 12 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.13M +1.1M (+100.0%) | 26.35M +26.3M (+100.0%) | 2.34% +2.341 pp | 0.04% +0.044 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 13 | CAPTION MANAGEMENT, LLC | 1.00M +— (+0.0%) | 23.42M +3.5M (+17.4%) | 2.08% -0.014 pp | 0.16% +0.005 pp | USD19.64 +19.2% | 3 qtrs — |
| 14 | D. E. SHAW & CO., INC. | 962.6K +73.7K (+8.3%) | 22.54M +4.8M (+27.1%) | 2.00% +0.141 pp | 0.01% +0.002 pp | USD20.04 +16.9% | 3 qtrs — |
| 15 | BIOIMPACT CAPITAL LLC | 941.4K +806.4K (+597.3%) | 22.05M +19.4M (+718.6%) | 1.96% +1.676 pp | 2.52% +2.082 pp | USD22.92 +2.2% | 2 qtrs — |
| 16 | ORBIMED ADVISORS LLC | 875.5K +186.5K (+27.1%) | 20.50M +6.8M (+49.2%) | 1.82% +0.379 pp | 0.42% +0.096 pp | USD17.27 +35.6% | 3 qtrs — |
| 17 | STATE STREET CORP | 807.4K -12.0K (-1.5%) | 18.91M +2.6M (+15.7%) | 1.68% -0.036 pp | 0.00% +0.000 pp | USD15.10 +55.1% | 31 qtrs — |
| 18 | FRONTIER CAPITAL MANAGEMENT CO LLC | 781.6K +781.6K (+100.0%) | 18.31M +18.3M (+100.0%) | 1.63% +1.626 pp | 0.19% +0.194 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 19 | MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 770.9K +— (+0.0%) | 18.06M +2.7M (+17.4%) | 1.60% -0.011 pp | 0.16% -0.010 pp | USD26.63 -12.1% | 28 qtrs — |
| 20 | CITADEL ADVISORS LLC | 737.8K +135.5K (+22.5%) | 17.28M +5.3M (+43.8%) | 1.54% +0.274 pp | 0.00% +0.001 pp | USD15.89 +47.4% | 14 qtrs — |
| 21 | SUPERSTRING CAPITAL MANAGEMENT LP | 718.4K +630.4K (+717.1%) | 16.82M +15.1M (+859.3%) | 1.49% +1.311 pp | 9.01% +7.279 pp | USD21.87 +7.1% | 5 qtrs — |
| 22 | TCG CROSSOVER MANAGEMENT, LLC | 717.3K +— (+0.0%) | 16.80M +2.5M (+17.4%) | 1.49% -0.010 pp | 0.56% -0.148 pp | USD19.95 +17.4% | 2 qtrs — |
| 23 | MILLENNIUM MANAGEMENT LLC | 619.0K -849.8K (-57.9%) | 14.50M -14.8M (-50.5%) | 1.29% -1.789 pp | 0.01% -0.006 pp | USD17.95 +30.5% | 23 qtrs — |
| 24 | PRICE T ROWE ASSOCIATES INC /MD/ | 616.6K +260.0K (+72.9%) | 14.44M +7.3M (+102.9%) | 1.28% +0.536 pp | 0.00% +0.001 pp | USD16.10 +45.5% | 8 qtrs — |
| 25 | J. GOLDMAN & CO LP | 513.3K +513.3K (+100.0%) | 12.02M +12.0M (+100.0%) | 1.07% +1.068 pp | 0.32% +0.316 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 26 | WOODLINE PARTNERS LP | 500.7K +194.4K (+63.4%) | 11.73M +5.6M (+91.9%) | 1.04% +0.400 pp | 0.05% +0.017 pp | USD19.15 +22.3% | 7 qtrs — |
| 27 | BOXER CAPITAL MANAGEMENT, LLC | 500.0K -75.0K (-13.0%) | 11.71M +238.8K (+2.1%) | 1.04% -0.164 pp | 2.56% -1.093 pp | USD13.70 +70.9% | 3 qtrs — |
| 28 | GEODE CAPITAL MANAGEMENT, LLC | 475.2K +4.0K (+0.8%) | 11.13M +1.7M (+18.4%) | 0.99% +0.002 pp | 0.00% +0.000 pp | USD13.59 +72.3% | 34 qtrs — |
| 29 | GOLDMAN SACHS GROUP INC | 459.7K +34.8K (+8.2%) | 10.77M +2.3M (+27.0%) | 0.96% +0.067 pp | 0.00% +0.000 pp | USD17.20 +36.2% | 33 qtrs — |
| 30 | VANGUARD GROUP INC | 439.8K +136.0K (+44.8%) | 10.30M +4.2M (+69.9%) | 0.92% +0.279 pp | 0.00% +0.000 pp | USD16.90 +38.6% | 11 qtrs — |
| 31 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 435.5K -252.0K (-36.7%) | 10.20M -3.5M (-25.6%) | 0.91% -0.534 pp | 0.04% -0.010 pp | USD19.95 +17.4% | 2 qtrs — |
| 32 | DEUTSCHE BANK AG\ | 366.7K +204.4K (+126.0%) | 8.59M +5.4M (+165.3%) | 0.76% +0.423 pp | 0.00% +0.002 pp | USD21.38 +9.5% | 11 qtrs — |
| 33 | TANG CAPITAL MANAGEMENT LLC | 350.0K -650.0K (-65.0%) | 8.20M -11.8M (-58.9%) | 0.73% -1.366 pp | 0.40% -0.363 pp | USD13.70 +70.9% | 3 qtrs — |
| 34 | NUVEEN, LLC | 302.6K -204.9K (-40.4%) | 7.09M -3.0M (-30.0%) | 0.63% -0.434 pp | 0.00% -0.001 pp | USD18.49 +26.7% | 4 qtrs — |
| 35 | RICE HALL JAMES & ASSOCIATES, LLC | 281.9K +22.7K (+8.8%) | 6.60M +1.4M (+27.7%) | 0.59% +0.044 pp | 0.36% +0.082 pp | USD14.76 +58.7% | 21 qtrs — |
| 36 | OPALEYE MANAGEMENT INC. | 268.4K +268.4K (+100.0%) | 6.29M +6.3M (+100.0%) | 0.56% +0.559 pp | 0.83% +0.829 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 37 | RENAISSANCE TECHNOLOGIES LLC | 244.3K -30.8K (-11.2%) | 5.72M +233.3K (+4.3%) | 0.51% -0.068 pp | 0.01% +0.002 pp | USD18.66 +25.5% | 5 qtrs — |
| 38 | TWO SIGMA INVESTMENTS, LP | 241.2K -145.0K (-37.5%) | 5.65M -2.1M (-26.7%) | 0.50% -0.307 pp | 0.01% -0.004 pp | USD16.90 +38.6% | 11 qtrs — |
| 39 | NORTHERN TRUST CORP | 237.5K -23.9K (-9.2%) | 5.56M +346.3K (+6.6%) | 0.49% -0.053 pp | 0.00% +0.000 pp | USD12.65 +85.1% | 31 qtrs — |
| 40 | UBS GROUP AG | 235.0K +54.6K (+30.2%) | 5.50M +1.9M (+52.9%) | 0.49% +0.111 pp | 0.00% +0.000 pp | USD13.75 +70.3% | 35 qtrs — |
| 41 | ATOM INVESTORS LP | 234.4K -57.5K (-19.7%) | 5.49M -334.5K (-5.7%) | 0.49% -0.124 pp | 0.44% -0.006 pp | USD10.91 +114.7% | 10 qtrs — |
| 42 | PRIVIUM FUND MANAGEMENT B.V. | 214.6K +18.0K (+9.2%) | 5.03M +1.1M (+28.1%) | 0.45% +0.035 pp | 0.93% +0.220 pp | USD15.73 +48.9% | 5 qtrs — |
| 43 | PARKMAN HEALTHCARE PARTNERS LLC | 168.8K -233.8K (-58.1%) | 3.95M -4.1M (-50.8%) | 0.35% -0.492 pp | 0.38% -0.462 pp | USD17.36 +34.9% | 10 qtrs — |
| 44 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 166.9K -202.8K (-54.9%) | 3.91M -3.5M (-47.0%) | 0.35% -0.427 pp | 0.00% 0.000 pp | USD13.59 +72.3% | 14 qtrs — |
| 45 | HENNION & WALSH ASSET MANAGEMENT, INC. | 161.9K +96.7K (+148.4%) | 3.79M +2.5M (+191.6%) | 0.34% +0.200 pp | 0.13% +0.084 pp | USD20.54 +14.0% | 3 qtrs — |
| 46 | EAM INVESTORS, LLC | 160.4K +160.4K (+100.0%) | 3.76M +3.8M (+100.0%) | 0.33% +0.334 pp | 0.42% +0.418 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 47 | AQR CAPITAL MANAGEMENT LLC | 153.4K -50.8K (-24.9%) | 3.59M -480.7K (-11.8%) | 0.32% -0.109 pp | 0.00% -0.001 pp | USD12.63 +85.4% | 9 qtrs — |
| 48 | SOLEUS CAPITAL MANAGEMENT, L.P. | 150.0K -529.0K (-77.9%) | 3.51M -10.0M (-74.1%) | 0.31% -1.110 pp | 0.13% -0.552 pp | USD13.70 +70.9% | 3 qtrs — |
| 49 | JPMORGAN CHASE & CO | 146.3K -388.3K (-72.6%) | 3.43M -7.2M (-67.9%) | 0.30% -0.815 pp | 0.00% 0.000 pp | USD13.60 +72.2% | 27 qtrs — |
| 50 | AMERIPRISE FINANCIAL INC | 136.0K +105.5K (+346.2%) | 3.19M +2.6M (+423.8%) | 0.28% +0.219 pp | 0.00% +0.001 pp | USD20.11 +16.5% | 14 qtrs — |
| 51 | HRT FINANCIAL LP | 130.9K -2.8K (-2.1%) | 3.07M +399.0K (+15.0%) | 0.27% -0.008 pp | 0.01% 0.000 pp | USD15.08 +55.3% | 3 qtrs — |
| 52 | BANK OF AMERICA CORP /DE/ | 128.6K +20.2K (+18.6%) | 3.01M +848.9K (+39.2%) | 0.27% +0.041 pp | 0.00% +0.000 pp | USD14.14 +65.6% | 31 qtrs — |
| 53 | WELLINGTON MANAGEMENT GROUP LLP | 126.0K +736.0 (+0.6%) | 2.95M +452.0K (+18.1%) | 0.26% 0.000 pp | 0.00% +0.000 pp | USD14.31 +63.7% | 10 qtrs — |
| 54 | FMR LLC | 123.6K +50.4K (+69.0%) | 2.89M +1.4M (+98.4%) | 0.26% +0.104 pp | 0.00% +0.000 pp | USD21.23 +10.3% | 16 qtrs — |
| 55 | ARK INVESTMENT MANAGEMENT LLC | 121.5K -5.2K (-4.1%) | 2.85M +317.1K (+12.5%) | 0.25% -0.013 pp | 0.02% +0.004 pp | USD12.71 +84.3% | 33 qtrs — |
| 56 | AISLING CAPITAL MANAGEMENT LP | 108.0K +108.0K (+100.0%) | 2.53M +2.5M (+100.0%) | 0.22% +0.225 pp | 0.53% +0.528 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 57 | BANK OF NEW YORK MELLON CORP | 98.8K +3.5K (+3.6%) | 2.31M +412.3K (+21.7%) | 0.21% +0.006 pp | 0.00% +0.000 pp | USD13.50 +73.5% | 11 qtrs — |
| 58 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 91.0K -70.0 (-0.1%) | 2.13M +314.3K (+17.3%) | 0.19% -0.001 pp | 0.00% +0.000 pp | USD12.75 +83.7% | 11 qtrs — |
| 59 | OAK RIDGE INVESTMENTS LLC | 85.2K -2.3K (-2.6%) | 2.00M +250.3K (+14.3%) | 0.18% -0.006 pp | 0.12% +0.008 pp | USD15.24 +53.7% | 8 qtrs — |
| 60 | WELLS FARGO & COMPANY/MN | 84.2K -41.8K (-33.2%) | 1.97M -542.1K (-21.6%) | 0.18% -0.089 pp | 0.00% 0.000 pp | USD11.52 +103.3% | 32 qtrs — |
| 61 | TD ASSET MANAGEMENT INC | 80.2K +36.2K (+82.2%) | 1.88M +1.0M (+113.9%) | 0.17% +0.075 pp | 0.00% +0.001 pp | USD16.41 +42.7% | 5 qtrs — |
| 62 | VOYA INVESTMENT MANAGEMENT LLC | 76.8K -6.8K (-8.2%) | 1.80M +129.7K (+7.8%) | 0.16% -0.015 pp | 0.00% +0.000 pp | USD15.78 +48.4% | 9 qtrs — |
| 63 | PANAGORA ASSET MANAGEMENT INC | 74.1K -110.3K (-59.8%) | 1.73M -1.9M (-52.9%) | 0.15% -0.232 pp | 0.01% -0.009 pp | USD12.76 +83.5% | 4 qtrs — |
| 64 | TRUIST FINANCIAL CORP | 72.3K +— (+0.0%) | 1.69M +250.8K (+17.4%) | 0.15% -0.001 pp | 0.00% +0.000 pp | USD17.28 +35.5% | 3 qtrs — |
| 65 | ALGERT GLOBAL LLC | 65.9K +65.9K (+100.0%) | 1.54M +1.5M (+100.0%) | 0.14% +0.137 pp | 0.02% +0.024 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 66 | JANE STREET GROUP, LLC | 60.6K -34.7K (-36.4%) | 1.42M -482.0K (-25.4%) | 0.13% -0.074 pp | 0.00% 0.000 pp | USD13.70 +70.9% | 3 qtrs — |
| 67 | ANNANDALE CAPITAL, LLC | 60.6K -10.0K (-14.2%) | 1.42M -12.7M (-89.9%) | 0.13% -0.022 pp | 0.17% -0.071 pp | USD18.02 +30.0% | 21 qtrs — |
| 68 | BARCLAYS PLC | 57.7K -2.0K (-3.4%) | 1.35M +593.2K (+78.1%) | 0.12% -0.005 pp | 0.00% +0.000 pp | USD13.09 +78.9% | 32 qtrs — |
| 69 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 55.7K +19.7K (+55.0%) | 1.29M +576.1K (+80.4%) | 0.12% +0.041 pp | 0.00% +0.001 pp | USD16.05 +45.9% | 9 qtrs — |
| 70 | NEOS INVESTMENT MANAGEMENT LLC | 53.6K +3.1K (+6.2%) | 1.25M +248.1K (+24.6%) | 0.11% +0.006 pp | 0.01% 0.000 pp | USD20.15 +16.2% | 2 qtrs — |
| 71 | RUSSELL INVESTMENTS GROUP, LTD. | 47.3K +43.9K (+1,323.0%) | 1.11M +1.0M (+1,570.5%) | 0.10% +0.091 pp | 0.00% +0.001 pp | USD23.15 +1.2% | 3 qtrs — |
| 72 | RHUMBLINE ADVISERS | 45.8K -5.2K (-10.2%) | 1.07M +55.2K (+5.4%) | 0.10% -0.012 pp | 0.00% +0.000 pp | USD13.20 +77.4% | 11 qtrs — |
| 73 | ADAR1 CAPITAL MANAGEMENT, LLC | 40.0K +— (+0.0%) | 936.8K +138.8K (+17.4%) | 0.08% -0.001 pp | 0.07% -0.006 pp | USD19.95 +17.4% | 2 qtrs — |
| 74 | JACOBS LEVY EQUITY MANAGEMENT, INC | 39.4K +18.0K (+84.2%) | 922.4K +495.9K (+116.3%) | 0.08% +0.037 pp | 0.00% +0.002 pp | USD21.54 +8.7% | 2 qtrs — |
| 75 | COASTAL BRIDGE ADVISORS, LLC | 37.0K +— (+0.0%) | 866.5K +128.4K (+17.4%) | 0.08% -0.001 pp | 0.06% +0.009 pp | USD18.00 +30.1% | 28 qtrs — |
| 76 | MEITAV INVESTMENT HOUSE LTD | 35.5K +4.0K (+12.7%) | 831.7K +203.1K (+32.3%) | 0.07% +0.008 pp | 0.01% +0.001 pp | USD16.96 +38.1% | 33 qtrs — |
| 77 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 35.4K +18.9K (+113.9%) | 828.9K +498.9K (+151.2%) | 0.07% +0.039 pp | 0.01% +0.003 pp | USD21.80 +7.4% | 2 qtrs — |
| 78 | COLONY GROUP, LLC | 35.3K +35.3K (+100.0%) | 826.2K +826.2K (+100.0%) | 0.07% +0.073 pp | 0.00% +0.001 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 79 | ALLIANCEBERNSTEIN L.P. | 35.0K +— (+0.0%) | 820.6K +121.6K (+17.4%) | 0.07% -0.001 pp | 0.00% +0.000 pp | USD11.33 +106.7% | 7 qtrs — |
| 80 | DARK FOREST CAPITAL MANAGEMENT LP | 31.5K +31.5K (+100.0%) | 738.1K +738.1K (+100.0%) | 0.07% +0.066 pp | 0.03% +0.034 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 81 | CETERA INVESTMENT ADVISERS | 30.1K -2.0K (-6.2%) | 704.8K +64.5K (+10.1%) | 0.06% -0.005 pp | 0.00% +0.000 pp | USD14.81 +58.1% | 3 qtrs — |
| 82 | HIGHVISTA STRATEGIES LLC | 28.0K -3.9K (-12.2%) | 655.9K +19.8K (+3.1%) | 0.06% -0.009 pp | 0.17% +0.013 pp | USD19.95 +17.4% | 2 qtrs — |
| 83 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 27.4K +27.4K (+100.0%) | 641.2K +641.2K (+100.0%) | 0.06% +0.057 pp | 0.01% +0.010 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 84 | INVESCO LTD. | 27.1K +4.7K (+21.1%) | 633.9K +187.9K (+42.1%) | 0.06% +0.010 pp | 0.00% +0.000 pp | USD17.71 +32.2% | 10 qtrs — |
| 85 | TOROSO INVESTMENTS, LLC | 27.0K +27.0K (+100.0%) | 631.7K +631.7K (+100.0%) | 0.06% +0.056 pp | 0.00% +0.002 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 86 | LOS ANGELES CAPITAL MANAGEMENT LLC | 31.6K +412.0 (+1.3%) | 626.6K +5.1K (+0.8%) | 0.07% +0.000 pp | 0.00% +0.000 pp | USD13.83 +69.3% | 3 qtrs — |
| 87 | PALO ALTO INVESTORS LP | 24.5K +— (+0.0%) | 573.8K +85.0K (+17.4%) | 0.05% 0.000 pp | 0.08% -0.011 pp | USD17.84 +31.3% | 24 qtrs — |
| 88 | MML INVESTORS SERVICES, LLC | 24.4K +24.4K (+100.0%) | 570.6K +570.6K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.001 pp | USD23.42 +0.0% | 1 qtrs NEW |
| 89 | QUANTINNO CAPITAL MANAGEMENT LP | 23.5K +3.2K (+15.8%) | 550.7K +145.5K (+35.9%) | 0.05% +0.006 pp | 0.00% +0.000 pp | USD15.02 +55.9% | 3 qtrs — |
| 90 | SQUAREPOINT OPS LLC | 22.8K +22.8K (+100.0%) | 534.7K +534.7K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.001 pp | USD23.42 +0.0% | 11 qtrs — |
| 91 | XTX TOPCO LTD | 22.5K -6.8K (-23.2%) | 526.7K -57.8K (-9.9%) | 0.05% -0.015 pp | 0.01% -0.017 pp | USD19.95 +17.4% | 6 qtrs — |
| 92 | METLIFE INVESTMENT MANAGEMENT, LLC | 22.4K -321.0 (-1.4%) | 525.7K +71.5K (+15.7%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD12.71 +84.3% | 11 qtrs — |
| 93 | INTECH INVESTMENT MANAGEMENT LLC | 22.2K +7.0K (+45.9%) | 520.2K +216.4K (+71.2%) | 0.05% +0.014 pp | 0.00% +0.002 pp | USD15.34 +52.7% | 6 qtrs — |
| 94 | SIMPLEX TRADING, LLC | 22.1K +22.1K (+100.0%) | 517.8K +517.8K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.000 pp | USD23.42 +0.0% | 17 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 65 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ARK Israel Innovative Technology ETF IZRL | 2.89% | 4.09M | 0.49% |
| 2 | Amplify BlueStar Israel Technology ETF ITEQ | 1.42% | 1.67M | 0.75% |
| 3 | Tema Oncology ETF CANC | 1.17% | 1.67M | 0.75% |
| 4 | American Century Small Cap Growth Insights ETF ACSG | 0.41% | 104.6K | 0.49% |
| 5 | iShares Micro-Cap ETF IWC | 0.37% | 5.52M | 0.60% |
| 6 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.21% | 2.40M | 0.40% |
| 7 | iShares Ageing Population UCITS ETF AGED.L | 0.16% | 1.43M | 0.40% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.13% | 96.4K | 0.35% |
| 9 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.13% | 1.44M | 0.35% |
| 10 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.13% | 598.1K | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.83
Neutral
Ratio by volume
3.00
Bullish
Buys
5
Sells
6
Shares acquired
65.9K
Shares disposed
20.7K
Cash buys
—
Cash sales
3.00
Net activity
+45,236
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | Smith Jason Drew | Officer | S-Sale | D | Ordinary Shares | 3,217 | 19.69 | 63.3K | 55,588 | D | ↗ |
| 2026-02-03 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 1,844 | 19.69 | 36.3K | 150,514 | D | ↗ |
| 2026-01-31 | Smith Jason Drew | Officer | M-Exempt | D | Restricted Stock Units | 6,667 | 0.00 | — | 0 | D | ↗ |
| 2026-01-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 3,333 | 0.00 | — | 3,334 | D | ↗ |
| 2026-01-31 | Degnan Chris | Officer | A-Award | A | Restricted Stock Units | 32,609 | 0.00 | — | 32,609 | D | ↗ |
| 2026-01-31 | Barrett Elizabeth A. | Officer | A-Award | A | Restricted Stock Units | 153,195 | 0.00 | — | 153,195 | D | ↗ |
| 2025-11-26 | Wildman Daniel George | Director | M-Exempt | D | Restricted Stock Unit | 2,000 | 0.00 | — | 6,000 | D | ↗ |
| 2025-11-26 | WEN LEANA | Director | M-Exempt | A | ordinary shares | 2,000 | 0.00 | — | 2,000 | D | ↗ |
| 2025-11-26 | Robinson James A. Jr. | Director | M-Exempt | D | Restricted Stock Unit | 2,000 | 0.00 | — | 6,000 | D | ↗ |
| 2025-11-26 | Holden Stuart | Director | M-Exempt | A | ordinary shares | 2,000 | 0.00 | — | 2,000 | D | ↗ |
| 2025-11-26 | BUTITTA CYNTHIA M | Director | M-Exempt | A | ordinary shares | 2,000 | 0.00 | — | 2,000 | D | ↗ |
| 2025-11-19 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 10,000 | 25.00 | 250.0K | 139,025 | D | ↗ |
| 2025-10-08 | Degnan Chris | Officer | M-Exempt | D | Restricted Stock Units | 4,483 | 0.00 | — | 8,967 | D | ↗ |
| 2025-09-08 | Smith Jason Drew | Officer | S-Sale | D | Ordinary Shares | 1,520 | 19.11 | 29.0K | 43,305 | D | ↗ |
| 2025-09-08 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 871 | 19.11 | 16.6K | 149,025 | D | ↗ |
| 2025-09-07 | Smith Jason Drew | Officer | M-Exempt | D | Restricted Stock Units | 3,333 | 0.00 | — | 3,334 | D | ↗ |
| 2025-09-07 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 1,667 | 0.00 | — | 1,667 | D | ↗ |
| 2025-08-26 | Wildman Daniel George | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 19.50 | 195.0K | 10,000 | D | ↗ |
| 2025-08-26 | WEN LEANA | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 19.50 | 195.0K | 10,000 | D | ↗ |
| 2025-08-26 | Robinson James A. Jr. | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 19.50 | 195.0K | 10,000 | D | ↗ |
| 2025-08-26 | Holden Stuart | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 19.50 | 195.0K | 10,000 | D | ↗ |
| 2025-08-26 | Belldegrun Arie | Director | A-Award | A | Stock Option (right ot buy) | 20,000 | 19.50 | 390.0K | 20,000 | D | ↗ |
| 2025-08-26 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 19.50 | 195.0K | 10,000 | D | ↗ |
| 2025-08-11 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 10,000 | 17.69 | 176.9K | 148,229 | D | ↗ |
| 2025-07-28 | Smith Jason Drew | Officer | S-Sale | D | Ordinary Shares | 7,522 | 19.14 | 144.0K | 41,492 | D | ↗ |
| 2025-07-28 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 10,000 | 0.00 | — | 163,378 | D | ↗ |
| 2025-07-28 | Barrett Elizabeth A. | Officer | A-Award | A | Performance Stock Units | 87,615 | 0.00 | — | 87,615 | D | ↗ |
| 2025-06-09 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 5,162 | 7.37 | 38.0K | 153,378 | D | ↗ |
| 2025-06-08 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 10,000 | 0.00 | — | 158,540 | D | ↗ |
| 2025-02-26 | Robinson James A. Jr. | Director | M-Exempt | D | Restricted Stock Unit | 2,000 | 0.00 | — | 4,000 | D | ↗ |
| 2025-01-31 | Smith Jason Drew | Officer | M-Exempt | A | Ordinary Shares | 5,500 | 0.00 | — | 35,281 | D | ↗ |
| 2025-01-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 1,334 | 0.00 | — | 0 | D | ↗ |
| 2025-01-31 | Barrett Elizabeth A. | Officer | A-Award | A | Restricted Stock Units | 96,377 | 0.00 | — | 96,377 | D | ↗ |
| 2024-10-08 | Degnan Chris | Officer | A-Award | A | Employee Stock Option (right to buy) | 74,142 | 13.11 | 972.0K | 74,142 | D | ↗ |
| 2024-09-09 | Smith Jason Drew | Officer | S-Sale | D | Ordinary Shares | 1,521 | 13.08 | 19.9K | 25,226 | — | ↗ |
| 2024-09-09 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 1,666 | 0.00 | — | 3,334 | — | ↗ |
| 2024-09-09 | Kim Dong | Officer | M-Exempt | D | Restricted Stock Units | 2,500 | 0.00 | — | 5,000 | — | ↗ |
| 2024-08-06 | Wildman Daniel George | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | WEN LEANA | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | Robinson James A. Jr. | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | Holden Stuart | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | Cohen Fred E | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | Belldegrun Arie | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-08-06 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 15.16 | 151.6K | 10,000 | — | ↗ |
| 2024-06-10 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 5,153 | 13.08 | 67.4K | 144,284 | — | ↗ |
| 2024-03-18 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 12,000 | 14.05 | 168.6K | 139,437 | — | ↗ |
| 2024-02-01 | Smith Jason Drew | Officer | S-Sale | D | Ordinary Shares | 3,328 | 15.78 | 52.5K | 23,414 | — | ↗ |
| 2024-02-01 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 1,894 | 15.78 | 29.9K | 151,437 | — | ↗ |
| 2024-01-31 | Smith Jason Drew | Officer | M-Exempt | D | Restricted Stock Units | 834 | 0.00 | — | 0 | — | ↗ |
| 2024-01-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 3,333 | 0.00 | — | 6,667 | — | ↗ |
| 2024-01-31 | Kim Dong | Officer | A-Award | A | Restricted Stock Units | 12,000 | 0.00 | — | 12,000 | — | ↗ |
| 2024-01-31 | Barrett Elizabeth A. | Officer | A-Award | A | Restricted Stock Units | 87,615 | 0.00 | — | 87,615 | — | ↗ |
| 2023-09-07 | Wildman Daniel George | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | WEN LEANA | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | Smith Jason Drew | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-09-07 | Schoenberg Mark | Officer | A-Award | A | Restricted Stock Units | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2023-09-07 | Robinson James A. Jr. | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | Kim Dong | Officer | A-Award | A | Restricted Stock Units | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2023-09-07 | Holden Stuart | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | Cohen Fred E | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | Belldegrun Arie | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-09-07 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right ot buy) | 10,000 | 16.85 | 168.5K | 10,000 | — | ↗ |
| 2023-08-31 | Smith Jason Drew | Officer | M-Exempt | A | Ordinary Shares | 8,334 | 0.00 | — | 22,207 | — | ↗ |
| 2023-07-26 | Cohen Fred E | Director | A-Award | A | Ordinary Shares | 69,339 | 9.54 | 661.5K | 69,339 | — | ↗ |
| 2023-07-25 | Robinson James A. Jr. | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 8.84 | 176.8K | 20,000 | — | ↗ |
| 2023-06-08 | Schoenberg Mark | Officer | A-Award | A | Restricted Stock Units | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2023-01-31 | Smith Jason Drew | Officer | M-Exempt | D | Restricted Stock Units | 833 | 0.00 | — | 834 | — | ↗ |
| 2023-01-31 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 991 | 10.12 | 10.0K | 147,888 | — | ↗ |
| 2023-01-31 | Kim Dong | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-01-31 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 5,000 | 0.00 | — | 0 | — | ↗ |
| 2023-01-20 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 122,677 | 5.00 | 613.4K | 146,627 | — | ↗ |
| 2022-11-08 | Wildman Daniel George | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-10-31 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 258 | 11.85 | 3.1K | 23,950 | — | ↗ |
| 2022-10-21 | Nussbaum Ran | Director | M-Exempt | D | Stock Option (right to buy) | 15,276 | 0.00 | — | 0 | — | ↗ |
| 2022-09-14 | Belldegrun Arie | Director | M-Exempt | A | Ordinary Shares | 160,000 | 5.00 | 800.0K | 408,693 | — | ↗ |
| 2022-09-08 | WEN LEANA | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-31 | Smith Jason Drew | Officer | M-Exempt | A | Ordinary Shares | 8,333 | 0.00 | — | 15,782 | — | ↗ |
| 2022-08-31 | Belldegrun Arie | Director | M-Exempt | A | Ordinary Shares | 3,241 | 5.00 | 16.2K | 248,693 | — | ↗ |
| 2022-07-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 500 | 0.00 | — | 1,000 | — | ↗ |
| 2022-06-16 | Nussbaum Ran | Director | M-Exempt | D | Stock Option (right to buy) | 2,211 | 5.00 | 11.1K | 0 | — | ↗ |
| 2022-06-08 | Nussbaum Ran | Director | A-Award | A | Stock Option (right to buy) | 6,817 | 0.00 | — | 6,817 | — | ↗ |
| 2022-06-08 | Holden Stuart | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-08 | Cohen Fred E | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 7.06 | 70.6K | 10,000 | — | ↗ |
| 2022-06-08 | Belldegrun Arie | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 7.06 | 70.6K | 10,000 | — | ↗ |
| 2022-06-08 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-06 | Nussbaum Ran | Director | M-Exempt | D | Stock Option (right to buy) | 1,030 | 0.00 | — | 0 | — | ↗ |
| 2022-04-30 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 254 | 6.62 | 1.7K | 23,467 | — | ↗ |
| 2022-03-25 | Kim Dong | Officer | A-Award | A | Employee Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-01-31 | Smith Jason Drew | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 7.72 | 231.6K | 30,000 | — | ↗ |
| 2022-01-31 | Schoenberg Mark | Officer | A-Award | A | Stock Option (right to buy) | 12,064 | 7.72 | 93.1K | 12,064 | — | ↗ |
| 2022-01-31 | Henderson Molly | Officer | M-Exempt | D | Restricted Stock Units | 666 | 0.00 | — | 1,334 | — | ↗ |
| 2022-01-31 | Barrett Elizabeth A. | Officer | S-Sale | D | Ordinary Shares | 5,960 | 7.58 | 45.2K | 308,358 | — | ↗ |
| 2022-01-26 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 111 | 8.09 | 897.99 | 22,095 | — | ↗ |
| 2022-01-04 | Barrett Elizabeth A. | Officer | S-Sale | D | Ordinary Shares | 46,968 | 9.15 | 429.8K | 298,220 | — | ↗ |
| 2022-01-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 105,689 | 0.00 | — | 345,188 | — | ↗ |
| 2021-11-30 | Smith Jason Drew | Officer | M-Exempt | D | Restricted Stock Units | 8,333 | 0.00 | — | 16,667 | — | ↗ |
| 2021-11-30 | Henderson Molly | Officer | M-Exempt | D | Restricted Stock Units | 5,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-11-18 | Schoenberg Mark | Officer | P-Purchase | A | Ordinary Shares | 160 | 13.10 | 2.1K | 21,997 | — | ↗ |
| 2021-11-01 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 258 | 17.16 | 4.4K | 21,837 | — | ↗ |
| 2021-10-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 500 | 0.00 | — | 2,500 | — | ↗ |
| 2021-10-27 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 107 | 16.32 | 1.7K | 21,595 | — | ↗ |
| 2021-10-26 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 208 | 0.00 | — | 21,702 | — | ↗ |
| 2021-08-02 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 243 | 15.64 | 3.8K | 21,494 | — | ↗ |
| 2021-07-31 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 500 | 0.00 | — | 3,000 | — | ↗ |
| 2021-07-26 | Schoenberg Mark | Officer | M-Exempt | D | Ordinary Shares | 208 | 0.00 | — | 20,924 | — | ↗ |
| 2021-06-07 | Tomasello Shawn | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-07 | Nussbaum Ran | Director | A-Award | A | Stock Option (right to buy) | 3,183 | 17.89 | 56.9K | 3,183 | — | ↗ |
| 2021-06-07 | Holden Stuart | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-07 | FALBERG KATHRYN E | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-07 | Cohen Fred E | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-07 | Belldegrun Arie | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-07 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 17.98 | 179.8K | 10,000 | — | ↗ |
| 2021-06-05 | Smith Jason Drew | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 17.98 | 269.7K | 15,000 | — | ↗ |
| 2021-06-05 | Henderson Molly | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 17.98 | 269.7K | 15,000 | — | ↗ |
| 2021-05-19 | Barrett Elizabeth A. | Officer | F-InKind | D | Ordinary Shares | 2,185 | 17.51 | 38.3K | 240,739 | — | ↗ |
| 2021-05-17 | Smith Jason Drew | Officer | P-Purchase | A | Common Stock | 2,500 | 15.71 | 39.3K | 2,500 | — | ↗ |
| 2021-05-17 | Henderson Molly | Officer | P-Purchase | A | Common Stock | 2,500 | 15.85 | 39.6K | 2,500 | — | ↗ |
| 2021-04-30 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 500 | 0.00 | — | 21,375 | — | ↗ |
| 2021-04-26 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 209 | 0.00 | — | 625 | — | ↗ |
| 2021-03-26 | Belldegrun Arie | Director | M-Exempt | A | Ordinary Shares | 3,241 | 5.00 | 16.2K | 245,452 | — | ↗ |
| 2021-03-25 | Nussbaum Ran | Director | M-Exempt | A | Ordinary Shares | 1,030 | 5.00 | 5.2K | 1,431,717 | — | ↗ |
| 2021-03-24 | Nussbaum Ran | Director | M-Exempt | D | Stock Option (right to buy) | 1,030 | 5.00 | 5.2K | 0 | — | ↗ |
| 2021-03-24 | Belldegrun Arie | Director | M-Exempt | D | Stock Option (right to buy) | 3,241 | 5.00 | 16.2K | 0 | — | ↗ |
| 2021-01-31 | Smith Jason Drew | Officer | A-Award | A | Stock Option (right to buy) | 8,000 | 22.07 | 176.6K | 8,000 | — | ↗ |
| 2021-01-31 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 2,000 | 0.00 | — | 21,831 | — | ↗ |
| 2021-01-31 | Henderson Molly | Officer | A-Award | A | Restricted Stock Units | 2,000 | 0.00 | — | 2,000 | — | ↗ |
| 2021-01-31 | Barrett Elizabeth A. | Director / Officer | A-Award | A | Stock Option (right to buy) | 150,000 | 22.07 | 3.31M | 150,000 | — | ↗ |
| 2021-01-26 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 208 | 0.00 | — | 19,931 | — | ↗ |
| 2021-01-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,807 | 0.00 | — | 237,924 | — | ↗ |
| 2020-12-14 | Barrett Elizabeth A. | Officer | P-Purchase | A | Ordinary Shares | 10,000 | 18.50 | 185.0K | 229,117 | — | ↗ |
| 2020-12-04 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 1,042 | 0.00 | — | 20,385 | — | ↗ |
| 2020-12-04 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 61,652 | 0.00 | — | 114,496 | — | ↗ |
| 2020-12-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,808 | 0.00 | — | 114,496 | — | ↗ |
| 2020-11-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,808 | 0.00 | — | 123,304 | — | ↗ |
| 2020-10-26 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 208 | 0.00 | — | 19,444 | — | ↗ |
| 2020-10-15 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | A | Ordinary Shares | 4,917 | 0.00 | — | 12,805 | — | ↗ |
| 2020-10-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,808 | 0.00 | — | 201,501 | — | ↗ |
| 2020-10-01 | Smith Jason Drew | Officer | A-Award | A | Restricted Stock Unit | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2020-10-01 | Henderson Molly | Officer | A-Award | A | Stock Option (Right to Buy) | 60,000 | 19.66 | 1.18M | 60,000 | — | ↗ |
| 2020-09-09 | Smith Jason Drew | Officer | A-Award | A | Restricted Stock Unit | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2020-09-04 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 1,041 | 0.00 | — | 1,042 | — | ↗ |
| 2020-09-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,807 | 0.00 | — | 140,920 | — | ↗ |
| 2020-09-01 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | D | Restricted Stock Units | 1,042 | 0.00 | — | 4,166 | — | ↗ |
| 2020-08-31 | Smith Jason Drew | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,807 | 0.00 | — | 183,886 | — | ↗ |
| 2020-07-27 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 70 | 23.51 | 1.6K | 18,543 | — | ↗ |
| 2020-07-27 | PFREUNDSCHUH PETER P. | Officer | S-Sale | D | Ordinary Shares | 141 | 23.51 | 3.3K | 7,355 | — | ↗ |
| 2020-07-26 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 209 | 0.00 | — | 1,250 | — | ↗ |
| 2020-07-26 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | D | Restricted Stock Units | 417 | 0.00 | — | 2,500 | — | ↗ |
| 2020-07-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,807 | 0.00 | — | 175,079 | — | ↗ |
| 2020-06-08 | Tomasello Shawn | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | Nussbaum Ran | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | Holden Stuart | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | FALBERG KATHRYN E | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | Cohen Fred E | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | Belldegrun Arie | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-08 | BUTITTA CYNTHIA M | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 28.24 | 282.4K | 10,000 | — | ↗ |
| 2020-06-04 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 1,042 | 0.00 | — | 18,753 | — | ↗ |
| 2020-06-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,807 | 0.00 | — | 167,341 | — | ↗ |
| 2020-05-20 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | D | Restricted Stock Units | 1,041 | 0.00 | — | 5,208 | — | ↗ |
| 2020-05-12 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 35,229 | 0.00 | — | 176,148 | — | ↗ |
| 2020-05-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,808 | 0.00 | — | 176,148 | — | ↗ |
| 2020-04-27 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 70 | 24.35 | 1.7K | 17,711 | — | ↗ |
| 2020-04-27 | PFREUNDSCHUH PETER P. | Officer | S-Sale | D | Ordinary Shares | 141 | 24.35 | 3.4K | 6,396 | — | ↗ |
| 2020-04-27 | Mullennix Stephen | Officer | S-Sale | D | Ordinary Shares | 145 | 24.35 | 3.5K | 10,084 | — | ↗ |
| 2020-04-26 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units | 208 | 0.00 | — | 1,459 | — | ↗ |
| 2020-04-26 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | A | Ordinary Shares | 417 | 0.00 | — | 6,537 | — | ↗ |
| 2020-04-26 | Mullennix Stephen | Officer | M-Exempt | A | Ordinary Shares | 417 | 0.00 | — | 10,229 | — | ↗ |
| 2020-04-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,807 | 0.00 | — | 148,657 | — | ↗ |
| 2020-03-04 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 1,042 | 0.00 | — | 17,918 | — | ↗ |
| 2020-03-03 | Barrett Elizabeth A. | Officer | M-Exempt | A | Ordinary Shares | 8,807 | 0.00 | — | 139,850 | — | ↗ |
| 2020-02-20 | PFREUNDSCHUH PETER P. | Officer | S-Sale | D | Ordinary Shares | 360 | 29.68 | 10.7K | 6,120 | — | ↗ |
| 2020-02-14 | Mullennix Stephen | Officer | M-Exempt | A | Ordinary Shares | 1,759 | 0.00 | — | 10,424 | — | ↗ |
| 2020-02-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Restricted Stock Units | 8,807 | 0.00 | — | 202,570 | — | ↗ |
| 2020-01-31 | Schoenberg Mark | Officer | A-Award | A | Stock options (right to buy) | 15,000 | 29.41 | 441.2K | 15,000 | — | ↗ |
| 2020-01-31 | PFREUNDSCHUH PETER P. | Officer | A-Award | A | Stock options (right to buy) | 15,000 | 29.41 | 441.2K | 15,000 | — | ↗ |
| 2020-01-31 | Mullennix Stephen | Officer | A-Award | A | Stock options (right to buy) | 15,000 | 29.41 | 441.2K | 15,000 | — | ↗ |
| 2020-01-31 | Barrett Elizabeth A. | Officer | A-Award | A | Stock options (right to buy) | 45,000 | 29.41 | 1.32M | 45,000 | — | ↗ |
| 2020-01-27 | Schoenberg Mark | Officer | S-Sale | D | Ordinary Shares | 322 | 29.15 | 9.4K | 9,177 | — | ↗ |
| 2020-01-27 | PFREUNDSCHUH PETER P. | Officer | S-Sale | D | Ordinary Shares | 667 | 29.28 | 19.5K | 4,438 | — | ↗ |
| 2020-01-27 | Mullennix Stephen | Officer | S-Sale | D | Ordinary Shares | 684 | 29.26 | 20.0K | 8,665 | — | ↗ |
| 2020-01-26 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units (RSUs) | 833 | 0.00 | — | 1,667 | — | ↗ |
| 2020-01-26 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | D | Restricted Stock Units (RSUs) | 1,666 | 0.00 | — | 3,334 | — | ↗ |
| 2020-01-26 | Mullennix Stephen | Officer | M-Exempt | D | Restricted Stock Units (RSUs) | 1,666 | 0.00 | — | 3,334 | — | ↗ |
| 2020-01-03 | Barrett Elizabeth A. | Officer | M-Exempt | D | Ordinary Shares | 105,688 | 0.00 | — | 211,377 | — | ↗ |
| 2019-12-04 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 1,042 | 0.00 | — | 9,009 | — | ↗ |
| 2019-11-21 | Barrett Elizabeth A. | Officer | P-Purchase | A | Ordinary Shares | 7,530 | 28.00 | 210.8K | 16,548 | — | ↗ |
| 2019-11-20 | PFREUNDSCHUH PETER P. | Officer | M-Exempt | D | Restricted Stock Units | 1,042 | 0.00 | — | 7,291 | — | ↗ |
| 2019-11-20 | Barrett Elizabeth A. | Officer | P-Purchase | A | Ordinary Shares | 7,470 | 28.00 | 209.2K | 9,018 | — | ↗ |
| 2019-11-19 | Schoenberg Mark | Officer | P-Purchase | A | Ordinary Shares | 1,960 | 28.17 | 55.2K | 7,967 | — | ↗ |
| 2019-11-15 | Barrett Elizabeth A. | Officer | P-Purchase | A | Ordinary Shares | 1,548 | 26.00 | 40.2K | 1,548 | — | ↗ |
| 2019-11-14 | Mullennix Stephen | Officer | S-Sale | D | Ordinary Shares | 608 | 26.00 | 15.8K | 7,683 | — | ↗ |
| 2019-09-04 | Schoenberg Mark | Officer | M-Exempt | A | Ordinary Shares | 1,041 | 0.00 | — | 6,350 | — | ↗ |
| 2019-08-20 | PFREUNDSCHUH PETER P. | Officer | S-Sale | D | Ordinary Shares | 1,416 | 33.07 | 46.8K | 2,751 | — | ↗ |
| 2019-08-15 | Mullennix Stephen | Officer | S-Sale | D | Ordinary Shares | 608 | 31.65 | 19.2K | 6,532 | — | ↗ |
| 2019-08-14 | Mullennix Stephen | Officer | M-Exempt | D | Restricted Stock Units | 1,759 | 0.00 | — | 10,555 | — | ↗ |
| 2019-06-04 | Schoenberg Mark | Officer | M-Exempt | D | Restricted Stock Units (RSUs) | 1,042 | 0.00 | — | 6,250 | — | ↗ |
| 2019-06-03 | Tomasello Shawn | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 34.83 | 348.3K | 10,000 | — | ↗ |
| 2019-06-03 | Nussbaum Ran | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 34.83 | 348.3K | 10,000 | — | ↗ |
| 2019-06-03 | Holden Stuart | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 34.83 | 348.3K | 10,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-474.5K
Shares Outstanding
48.68M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Elizabeth Barrett Chief Executive Officer | 855.6K | 774.1K | 2.12M | — | 516.3K | 42.5K | 4.31M | 49.23% | ↗ |
| 2 | 2025 | Jason Smith General Counsel and Chief Compliance Officer | 492.0K | 199.0K | 220.2K | — | 197.9K | 89.5K | 1.20M | 18.37% | ↗ |
| 3 | 2025 | Mark Schoenberg Chief Medical Officer | 369.6K | 167.5K | 440.4K | — | 180.0K | 13.1K | 1.17M | 37.62% | ↗ |
| 4 | 2024 | Elizabeth Barrett Chief Executive Officer | 826.0K | — | 2.75M | — | 530.0K | 42.8K | 4.15M | 66.29% | ↗ |
| 5 | 2024 | Don Kim Former Chief Financial Officer | 363.7K | — | 376.8K | — | — | 623.7K | 1.36M | 27.62% | ↗ |
| 6 | 2024 | Jason Smith General Counsel and Chief Compliance Officer | 475.0K | — | 518.1K | — | 203.2K | 79.2K | 1.28M | 40.62% | ↗ |
| 7 | 2024 | Chris Degnan Chief Financial Officer | 115.5K | — | 176.3K | 695.3K | 53.1K | 13.5K | 1.05M | 82.71% | ↗ |
| 8 | 2024 | Mark Schoenberg Chief Medical Officer | 354.2K | — | 314.0K | — | 202.5K | 8.1K | 878.9K | 35.73% | ↗ |
| 9 | 2023 | Elizabeth Barrett Chief Executive Officer | 794.2K | 20.0K | 2.46M | 836.5K | 479.6K | 45.0K | 4.64M | 71.14% | ↗ |
| 10 | 2023 | Jason Smith General Counsel and Chief Compliance Officer | 456.7K | 48.0K | 376.3K | 267.7K | 275.8K | 83.7K | 1.51M | 42.70% | ↗ |
| 11 | 2023 | Mark P. Schoenberg, M.D. Chief Medical Officer | 341.5K | 26.3K | 520.0K | 200.8K | 270.0K | 2.1K | 1.36M | 52.97% | ↗ |
| 12 | 2022 | Elizabeth Barrett Chief Executive Officer | 764.3K | — | — | 753.2K | 307.4K | 45.6K | 1.87M | 40.27% | ↗ |
| 13 | 2022 | Jason Smith General Counsel and Chief Compliance Officer | 440.0K | 10.0K | 57.9K | 150.6K | 198.9K | 68.7K | 926.1K | 22.52% | ↗ |
| 14 | 2022 | Don Kim Chief Financial Officer | 354.3K | — | 77.2K | 114.1K | 148.0K | 44.4K | 738.0K | 25.93% | ↗ |
| 15 | 2022 | Mark P. Schoenberg, M.D. Chief Medical Officer | 326.0K | — | 30.9K | 60.6K | 180.0K | 2.2K | 599.6K | 15.25% | ↗ |
| 16 | 2021 | Elizabeth Barrett Chief Executive Officer | 739.0K | — | 882.8K | 2.23M | 315.6K | 45.1K | 4.21M | 73.89% | ↗ |
| 17 | 2021 | Jason Smith General Counsel and Chief Compliance Officer | 429.3K | 30.0K | 55.2K | 296.8K | 182.8K | 64.7K | 1.06M | 33.24% | ↗ |
| 18 | 2021 | Mark Schoenberg Chief Medical Officer | 284.9K | — | 132.4K | 312.2K | 293.2K | 1.4K | 1.02M | 43.42% | ↗ |
| 19 | 2021 | Molly Henderson Former Chief Financial Officer | 434.1K | — | 44.1K | 267.0K | 99.7K | 59.8K | 904.8K | 34.39% | ↗ |
| 20 | 2020 | Elizabeth Barrett Chief Executive Officer | 637.0K | — | 441.2K | 876.2K | 468.7K | 43.7K | 2.47M | 53.40% | ↗ |
| 21 | 2020 | Jason Smith General Counsel and Chief Compliance Officer | 126.9K | 100.0K | 491.5K | 785.2K | 92.1K | 19.5K | 1.62M | 79.04% | ↗ |
| 22 | 2020 | Molly Henderson Former Chief Financial Officer | 94.3K | 100.0K | 294.9K | 788.0K | 69.9K | 15.2K | 1.36M | 79.49% | ↗ |
| 23 | 2020 | Molly Henderson Chief Financial Officer | 94.3K | 100.0K | 294.9K | 788.0K | 69.9K | 15.2K | 1.36M | 79.49% | ↗ |
| 24 | 2020 | Peter P. Pfreundschuh Chief Financial Officer | 324.3K | — | 176.5K | 292.1K | 218.8K | 152.3K | 1.16M | 40.25% | ↗ |
| 25 | 2020 | Mark Schoenberg Chief Medical Officer | 185.0K | — | 176.5K | 92.1K | 293.2K | 1.8K | 948.5K | 28.31% | ↗ |
| 26 | 2020 | Stephen L. Mullennix Chief Operating Officer | 139.3K | — | 88.2K | 292.1K | 140.2K | 246.6K | 906.4K | 41.96% | ↗ |
| 27 | 2019 | Elizabeth Barrett Chief Executive Officer | 694.7K | 300.0K | 15.08M | 8.98M | 840.0K | 4.1K | 25.90M | 92.90% | ↗ |
| 28 | 2019 | Peter P. Pfreundschuh Chief Financial Officer | 435.6K | — | 212.5K | 436.1K | 261.4K | 1.2K | 1.35M | 48.16% | ↗ |
| 29 | 2019 | Stephen L. Mullennix Chief Operating Officer | 435.6K | — | 212.5K | 436.1K | 261.4K | 904.00 | 1.35M | 48.17% | ↗ |
| 30 | 2019 | Mark Schoenberg Chief Medical Officer | 205.0K | — | 106.3K | 218.1K | 270.0K | 1.6K | 800.9K | 40.49% | ↗ |
| 31 | 2019 | Ron Bentsur Former Chief Executive Officer | 5.8K | — | — | — | — | 2.3K | 8.1K | 0.00% | ↗ |
| 32 | 2018 | Ron Bentsur Former Chief Executive Officer | 610.2K | — | — | 1.74M | 334.0K | 3.27M | 5.95M | 29.24% | ↗ |
| 33 | 2018 | Stephen L. Mullennix Chief Operating Officer | 359.8K | 70.0K | 1.10M | 2.55M | 223.4K | 575.00 | 4.31M | 84.83% | ↗ |
| 34 | 2018 | Stephen Mullennix Chief Operating Officer and Interim Chief Financial Officer | 359.8K | 70.0K | 1.10M | 2.55M | 223.4K | 575.00 | 4.31M | 84.83% | ↗ |
| 35 | 2018 | Gil Hakim Former President | 330.8K | — | — | 1.04M | — | 2.48M | 3.86M | 27.07% | ↗ |
| 36 | 2018 | Gary Titus Former Chief Financial Officer | 175.0K | — | — | 695.8K | — | 2.62M | 3.49M | 19.95% | ↗ |
| 37 | 2018 | Peter Pfreundschuh Chief Financial Officer | 156.4K | — | 527.9K | 1.70M | 96.8K | 197.00 | 2.49M | 89.81% | ↗ |
| 38 | 2018 | Peter P. Pfreundschuh Chief Financial Officer | 156.4K | — | 527.9K | 1.70M | 96.8K | 197.00 | 2.49M | 89.81% | ↗ |
| 39 | 2018 | Mark Schoenberg Chief Medical Officer | 200.0K | — | — | — | 100.0K | — | 300.0K | 0.00% | ↗ |
| 40 | 2017 | Ron Bentsur Former Chief Executive Officer | 414.3K | — | — | 1.24M | 226.0K | 87.7K | 1.97M | 63.10% | ↗ |
| 41 | 2017 | Gil Hakim Former President | 390.4K | — | — | 778.7K | 114.2K | 60.2K | 1.34M | 57.96% | ↗ |
| 42 | 2017 | Gary Titus Former Chief Financial Officer | 304.2K | 25.0K | — | 622.2K | 125.1K | 1.2K | 1.08M | 57.74% | ↗ |
| 43 | 2017 | Mark Schoenberg Chief Medical Officer | 13.6K | 75.0K | 490.8K | 468.7K | 6.0K | — | 1.05M | 91.02% | ↗ |
| 44 | 2016 | Mark Schoenberg Chief Medical Officer | — | — | — | 3.40M | — | — | 3.40M | 100.00% | ↗ |
| 45 | 2016 | Gil Hakim Former President | 207.9K | — | — | 87.8K | 84.3K | 41.0K | 421.0K | 20.87% | ↗ |
| 46 | 2016 | Gary Titus Former Chief Financial Officer | 314.1K | — | — | 87.8K | — | 452.00 | 402.4K | 21.83% | ↗ |
| 47 | 2016 | Ron Bentsur Former Chief Executive Officer | 313.0K | — | — | — | — | 86.1K | 399.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Elizabeth A. Barrett | President, Chief Executive Officer & Director | 1M | female |
| Jason Drew Smith | General Counsel, Chief Compliance Officer & Corporate Secretary | 757.4K | male |
| Ron Bentsur | Advisor | 699.8K | male |
| Mark Schoenberg | Chief Medical Officer | 639.8K | — |
| Christopher Degnan | Chief Financial Officer | 561.8K | male |
| Michael J. Louie | Chief Development Officer | — | male |
| Timothy Simon | Senior Vice President of Business Development & Portfolio Strategy | — | male |
| Alison Hardgrove | Senior Vice President of Human Resources | — | female |
| Vincent I. Perrone | Senior Director of Investor Relations | — | male |
| Bryon Wornson | Executive Vice President of Talent, Advocacy & Communications | — | male |
| David Lin | Chief Commercial Officer | — | male |
| James Ottinger | Executive Vice President of Regulatory Affairs & Quality | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for URGN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
